IBRX ImmunityBio, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 4, 2026
$10,29
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,9552 haftanın en düşüğü
$12,4352 haftanın en yükseği
Piyasa Değeri (MRQ)
$10.83B
P/E (TTM)
-10.6
Hisse Başına Kâr (TTM)
$-0.97
Gelir (TTM)
$166M
rozetleriniz
52 Haftlık Aralık
$2–$12
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$13
P/E
-10.6
ROE
122.7%
Net Kâr Marjı
-598.6%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
IBRX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$10.29
Piyasa Değeri (MRQ)
$10.83B
P/E (TTM)
-10.6
Hisse Başına Kâr (TTM)
$-0.97
Gelir (TTM)
$166M
ROE (TTM)
122.7%
52 Haftlık Aralık
$2–$12
IBRX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$113M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-0.382019-12-31 → 2025-12-31
Serbest Nakit Akışı$-309M2016-12-31 → 2025-12-31
Net kar marjı-598.6%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | IBRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -10.65Y ort. ≈-5.1 | ≈-5.1 | · | · | |
| F/S (TTM) | 65.35Y ort. ≈3415.1 | ≈3415.1 | 28.1 | Aşırı değerli | |
| F/D (MRQ) | -10.35Y ort. ≈-5.8 | ≈-5.8 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -37.65Y ort. ≈-6.7 | ≈-6.7 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -38.55Y ort. ≈-7.3 | ≈-7.3 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | IBRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -151.9%5Y ort. ≈-48507.2% | ≈-48507.2% | -34.4% | Zayıf | |
| FAVÖK Marjı (TTM) | -141.9%5Y ort. ≈-46058.8% | ≈-46058.8% | -34.4% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -598.7%5Y ort. ≈-61662.8% | ≈-61662.8% | -42.3% | Zayıf | |
| Net Kâr Marjı (TTM) | -598.6%5Y ort. ≈-61515.1% | ≈-61515.1% | -42.8% | Zayıf | |
| ROA (TTM) | -192.6%5Y ort. ≈-101.6% | ≈-101.6% | -20.4% | Zayıf | |
| ROE (TTM) | 122.7%5Y ort. ≈114.6% | ≈114.6% | -23.4% | En üst düzey | |
| ROIC | 51.1%5Y ort. ≈79.6% | ≈79.6% | -21.5% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | IBRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 5.75Y ort. ≈2.9 | ≈2.9 | 6.5 | Düşük likidite | |
| Cari Oran (MRQ) | 5.45Y ort. ≈2.6 | ≈2.6 | 5.4 | Aynı seviyede | |
| Interest Coverage (Faiz Karşılama Oranı) | -4.25Y ort. ≈-7.6 | ≈-7.6 | -13.2 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | IBRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 668.3%5Y ort. ≈615.6% | ≈615.6% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 678.6%5Y ort. ≈276.8% | ≈276.8% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 184.8% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | IBRX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.35Y ort. ≈0.1 | ≈0.1 | 0.2 | En üst düzey | |
| Inventory Turnover (Stok Devir Hızı) | 0.2 | · | 1.1 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 5.0 | · | 6.6 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$165.6K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-13.6%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 12, 2026 | $-0.22 | $-0.09 | -139.7% |
| 31 Mart 2026 | May 11, 2026 | $-0.08 | $-0.07 | -12.0% |
| 31 Aralık 2025 | $-0.06 | $-0.10 | 37.4% | |
| 30 Eylül 2025 | $-0.07 | $-0.11 | 36.5% | |
| 30 Haziran 2025 | $-0.10 | $-0.11 | 10.9% | |
| 31 Mart 2025 | $-0.15 | $-0.13 | -14.9% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113M | $15M | $622.0K | $240.0K | $934.0K | $605.0K | $2M | $47.0K | $45.0K | $44.0K | $236.0K | $641.0K | |
| Cost of Revenue | $753.0K | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| R&D Expense | · | $190M | $232M | $248M | $196M | $140M | $112M | $56M | $42M | $29M | $11M | $2M | |
| SG&A Expense | · | $169M | $130M | $103M | $135M | $71M | $46M | $43M | $57M | $95M | $228M | $5M | |
| Operating Expenses | $369M | $359M | $363M | $352M | $331M | $221M | $158M | $98M | $99M | $125M | $239M | $6M | |
| Operating Income | $-256M | $-344M | $-362M | $-351M | $-330M | $-221M | $-156M | $-98M | $-99M | $-124M | $-239M | $-6M | |
| Interest Expense | $61M | $115M | $129M | $64M | $15M | $9M | $6M | · | $618.0K | $66.0K | $0 | $471.0K | |
| Interest Income | · | · | · | · | · | $1M | $2M | $2M | $4M | $5M | $312.0K | $20.0K | |
| Other Non-op | $-2M | $-15.0K | $-2M | $-736.0K | $193.0K | $1M | $-534.0K | $236.0K | $157.0K | $88.0K | $77.0K | $0 | |
| Pretax Income | $-352M | $-414M | $-584M | $-417M | $-350M | $-226M | $-160M | $-97M | $-97M | $-121M | $-237M | $-6M | |
| Income Tax | $-135.0K | $0 | $-40.0K | $34.0K | $9.0K | $-2M | $-105.0K | $-503.0K | $-493.0K | $-572.0K | $-301.0K | $1.0K | |
| Net Income | $-351M | $-414M | $-583M | $-417M | $-347M | $-222M | $-158M | $-96M | $-96M | $-121M | $-237M | $-6M | |
| EPS (Basic) | $-0.38 | $-0.59 | $-1.15 | $-1.04 | $-0.89 | $-0.59 | $-0.43 | · | · | · | · | · | |
| EPS (Diluted) | $-0.38 | $-0.62 | $-1.15 | $-1.04 | $-0.89 | $-0.59 | $-0.43 | · | · | · | · | · | |
| Shares (Basic) | 919,863,000 | 697,312,000 | 508,636,000 | 399,900,000 | 389,234,156 | 377,067,527 | 366,324,859 | · | · | · | · | · | |
| Shares (Diluted) | 919,863,000 | 700,443,000 | 508,636,000 | 399,900,000 | 389,234,156 | 377,067,527 | 366,324,859 | · | · | · | · | · | |
| EBITDA | $-241M | $-327M | $-344M | $-333M | $-316M | $-82M | $-59M | $-89M | $-94M | $-121M | $1M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $143M | $265M | $105M | $181M | $35M | $76M | $17M | $24M | $8M | $176M | $59M | |
| Short-term Investments | $154M | $6M | $1M | $3M | $136M | $61M | · | · | $104M | $191M | $118M | · | |
| Receivables | $43M | $2M | $0 | · | · | · | · | · | · | · | · | $145.0K | |
| Inventory | $910.0K | $8M | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $29M | $24M | $26M | $32M | $16M | $14M | $4M | $14M | $4M | $5M | $3M | $124.0K | |
| Other Current Assets | $2M | $1M | $2M | $2M | $3M | $110.0K | $24.0K | $42.0K | $275.0K | $275.0K | $0 | · | |
| Current Assets | $315M | $185M | $294M | $141M | $334M | $112M | $56M | $89M | $132M | $205M | $298M | $59M | |
| PP&E (Net) | $114M | $137M | $146M | $144M | $83M | $73M | $61M | $77M | $77M | $19M | $6M | $211.0K | |
| PP&E (Gross) | $227M | $237M | $230M | $213M | $136M | $114M | $79M | $88M | $81M | $20M | $6M | $257.0K | |
| Accum. Depreciation | $112M | $100M | $84M | $69M | $53M | $42M | $19M | $12M | $4M | $1M | $167.0K | $46.0K | |
| Goodwill | $910.0K | $910.0K | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $13M | $15M | $17M | $20M | $1M | $1M | $0 | $565.0K | $3M | $5M | $7M | $3.0K | |
| Other Non-current Assets | · | $5M | $3M | $5M | $7M | $3M | $4M | $2M | $330.0K | $788.0K | $1M | $409.0K | |
| Total Assets | $502M | $383M | $504M | $362M | $469M | $221M | $143M | $182M | $250M | $317M | $367M | $61M | |
| Accounts Payable | · | · | · | $21M | $11M | $12M | $2M | $3M | $6M | $4M | $2M | $1M | |
| Accrued Liabilities | $47M | $41M | $43M | $42M | $51M | $37M | $5M | $21M | $11M | $6M | $3M | $311.0K | |
| Short-term Debt | · | · | $0 | $432M | · | · | · | · | · | · | · | $265.0K | |
| Current Liabilities | $62M | $55M | $58M | $501M | $369M | $68M | $12M | $27M | $21M | $13M | $6M | $2M | |
| Capital Leases | $33M | $35M | $40M | $48M | $37M | $16M | $11M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | $162.0K | $170.0K | · | $0 | $498.0K | $996.0K | $1M | · | |
| Other Non-current Liabilities | $424.0K | $319.0K | $1M | $457.0K | $411.0K | $1M | · | $0 | $255.0K | $240.0K | $0 | · | |
| Total Liabilities | $1.00B | $871M | $1.09B | $812M | $713M | $340M | $22M | $36M | $32M | $24M | $11M | $2M | |
| Total Debt | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Common Stock | $101.0K | $85.0K | $67.0K | $42.0K | $40.0K | $38.0K | $10.0K | $8.0K | $8.0K | $8.0K | $8.0K | · | |
| Retained Earnings | $-3.73B | $-3.38B | $-2.96B | $-2.38B | $-1.96B | $-1.62B | $-662M | $-595M | $-499M | $-387M | $-250M | $-13M | |
| AOCI | $29M | $1M | $10.0K | $183.0K | $4.0K | $122.0K | $-105.0K | $-267.0K | $-381.0K | $-284.0K | $-192.0K | · | |
| Stockholders' Equity | $-500M | $-489M | $-587M | $-447M | $-242M | $-120M | $121M | $146M | $219M | $293M | $356M | $58M | |
| Liabilities + Equity | $502M | $383M | $504M | $362M | $469M | $221M | $143M | $182M | $250M | $317M | $367M | $61M | |
| Shares Outstanding | 1,011,800,008 | 852,904,340 | 670,867,344 | 421,569,115 | 397,830,044 | 382,243,142 | 371,976,995 | 348,677,955 | 79,021,878 | 81,983,937 | 81,311,686 | · |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $18M | $19M | $18M | $14M | $13M | $14M | $10M | $6M | $4M | $1M | $36.0K | |
| Stock-based Comp | $37M | $34M | $49M | $40M | $57M | $2M | $3M | $23M | $37M | $74M | $211M | $789.0K | |
| Deferred Tax | $-139.0K | $0 | $-14.0K | $-4.0K | $-8.0K | $-3M | $-8.0K | $-498.0K | $-497.0K | $-575.0K | $-302.0K | $0 | |
| Amort. of Intangibles | · | $2M | $2M | $2M | · | · | $600.0K | $2M | $2M | $3M | $1M | $0 | |
| Other Non-cash | $-6M | $-30M | $149M | $21M | $960.0K | $11M | $-7M | $406.0K | $6M | $5M | $-820.0K | · | |
| Operating Cash Flow | $-305M | $-391M | $-367M | $-338M | $-274M | $-172M | $-152M | $-63M | $-49M | $-39M | $-25M | $-5M | |
| CapEx | $4M | $7M | $31M | $78M | $34M | $2M | $4M | $13M | $35M | $7M | $2M | $235.0K | |
| Investing Cash Flow | $-150M | $-12M | $-30M | $27M | $-85M | $-20M | $19M | $57M | $100M | $-114M | · | · | |
| Stock Issued | · | · | · | $60M | $165M | $86M | $30M | $0 | · | $0 | $0 | $1M | |
| Stock Repurchased | · | · | · | · | $0 | $0 | $3M | $228.0K | $15M | $16M | $5M | $0 | |
| Net Stock Activity | · | · | · | $60M | $165M | $86M | $-501.0K | $-228.0K | $-15M | $-16M | $-5M | · | |
| Financing Cash Flow | $400M | $282M | $558M | $234M | $505M | $151M | $114M | $-771.0K | $-35M | $-16M | · | · | |
| Net Change in Cash | $-54M | $-122M | $161M | $-76M | $146M | $-41M | $-19M | · | $16M | $-168M | $117M | $59M | |
| Taxes Paid | $0 | $15.0K | $8.0K | $2.0K | $9.0K | $8.0K | $3.0K | $4.0K | $3.0K | $2.0K | $1.0K | $1.0K | |
| Free Cash Flow | $-309M | $-398M | $-397M | $-416M | $-308M | $-73M | $-66M | $-76M | $-84M | $-45M | $-28M | · | |
| Levered FCF | $-370M | $-513M | $-527M | $-479M | $-323M | · | · | · | $-84M | $-45M | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -226.0% | -2334.2% | -58239.5% | -146374.2% | -35361.9% | -82546.0% | -157690.7% | -209338.3% | -220266.7% | -282954.6% | · | · | |
| Net Margin | -310.2% | -2804.8% | -93761.4% | -173569.6% | -37129.6% | -83227.9% | -152997.7% | -204736.2% | -214273.3% | -274565.9% | -100371.2% | · | |
| Pretax Margin | -310.4% | -2805.3% | -93873.3% | -173869.2% | -37456.0% | -83223.4% | -153223.3% | -205806.4% | -215368.9% | -275865.9% | · | · | |
| EBITDA Margin | -212.3% | -2215.2% | -55263.3% | -138765.8% | -33837.5% | -74305.4% | -136732.6% | -189008.5% | -207897.8% | -274756.8% | 623.7% | · | |
| ROA | -79.4% | -93.2% | -134.6% | -100.2% | -100.5% | -62.6% | -40.5% | -44.5% | -34.0% | -35.3% | · | · | |
| ROE | 71.0% | 76.9% | 112.8% | 120.8% | 191.6% | -64.4% | -51.3% | -62.5% | -37.6% | -37.2% | -114.5% | · | |
| ROIC | 51.1% | 70.4% | 61.7% | 78.5% | 136.4% | -78.0% | -56.1% | -67.0% | -45.1% | -42.2% | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 3.4 | 5.0 | 0.3 | 0.9 | 3.1 | 4.8 | 3.3 | 6.3 | 16.3 | · | · | |
| Quick Ratio | 4.6 | 2.8 | 4.6 | 0.2 | 0.9 | 0.5 | 1.3 | 0.6 | 6.1 | 15.8 | 47.9 | · | |
| Debt / Equity | · | · | 0.0 | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | -4.2 | -3.0 | -2.8 | -5.5 | -22.2 | · | · | · | -160.4 | -1886.4 | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.2 | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 5.0 | 12.5 | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.49 | $-0.57 | $-0.88 | $-1.06 | $-0.61 | $1.08 | $1.23 | $1.85 | $2.77 | $3.58 | · | · | |
| Revenue / Share | $0.12 | $0.02 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.33 | $-0.56 | $-0.72 | $-0.84 | $-0.70 | · | · | · | · | · | · | · | |
| Cash / Share | $0.09 | $0.17 | $0.40 | $0.25 | $0.46 | $0.11 | $0.16 | $0.21 | $0.30 | $0.10 | · | · | |
| EPS (TTM) | $-0.38 | $-0.62 | $-1.15 | $-1.04 | $-0.89 | $-0.59 | $-0.43 | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 668.3% | 2270.6% | 159.2% | -74.3% | 54.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 678.6% | 150.9% | 0.93% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 184.8% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $113M | $15M | $622.0K | $240.0K | $934.0K | $605.0K | $2M | $47.0K | $45.0K | $44.0K | $236.0K | · | |
| Net Income TTM | $-351M | $-414M | $-583M | $-417M | $-347M | $-222M | $-158M | $-96M | $-96M | $-121M | $-237M | · | |
| Market Cap | $2.00B | $2.18B | $3.37B | $2.14B | $2.42B | $1.45B | $373M | $92M | $355M | $469M | · | · | |
| Enterprise Value | · | · | $3.10B | · | · | · | · | · | · | · | · | · | |
| P/E | -5.2 | -4.1 | -4.4 | -4.9 | -6.8 | -22.6 | -8.8 | · | · | · | · | · | |
| P/S | 17.7 | 148.1 | 5414.4 | 8905.6 | 2589.7 | 2395.6 | 169.5 | 1952.0 | 7884.6 | 10657.9 | · | · | |
| P/B | -4.0 | -4.5 | -5.7 | -4.8 | -10.0 | 12.3 | 3.1 | 0.6 | 1.6 | 1.6 | · | · | |
| P / Cash Flow | -6.6 | -5.6 | -9.2 | -6.3 | -8.8 | -20.6 | -6.1 | -1.4 | -7.3 | -12.2 | · | · | |
| P / FCF | -6.5 | -5.5 | -8.5 | -5.1 | -7.9 | -19.8 | -5.7 | -1.2 | -4.2 | -10.4 | · | · | |
| EV / EBITDA | · | · | -9.0 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | · | -7.8 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | 4986.0 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -19.2% | -24.2% | -22.9% | -20.5% | -14.6% | -4.4% | -11.3% | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $51M | $44M | $38M | $32M | $26M | $17M | $8M | $6M | $1M | $40.0K | $139.0K | $82.0K | $41.0K | $360.0K | $73.0K | $118.0K | |
| Cost of Revenue | $298.0K | $238.0K | $382.0K | $177.0K | $136.0K | $58.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | |
| R&D Expense | · | · | · | · | · | · | · | $50M | $51M | $53M | · | $48M | $53M | $79M | $58M | $72M | |
| SG&A Expense | · | · | · | · | · | · | · | $36M | $49M | $42M | · | $32M | $32M | $33M | $26M | $19M | |
| Operating Expenses | $113M | $114M | $103M | $88M | $98M | $81M | $77M | $86M | $100M | $95M | $86M | $80M | $85M | $112M | $85M | $91M | |
| Operating Income | $-62M | $-70M | $-65M | $-56M | $-71M | $-64M | $-69M | $-80M | $-99M | $-95M | $-85M | $-80M | $-85M | $-112M | $-85M | $-91M | |
| Interest Expense | · | · | $15M | $15M | $15M | $15M | $26M | $29M | $30M | $29M | $32M | $35M | $32M | $30M | $29M | $17M | |
| Other Non-op | $242.0K | $-6M | $-2M | $-187.0K | $-278.0K | $-41.0K | $10.0K | $12.0K | $-17.0K | $-20.0K | $-71.0K | $-1M | $-28.0K | $-1M | $-923.0K | $6.0K | |
| Pretax Income | $-230M | $-633M | $-62M | $-67M | $-92M | $-130M | $-59M | $-86M | $-135M | $-134M | $-233M | $-96M | $-138M | $-117M | $-108M | $-111M | |
| Income Tax | $0 | $9.0K | $-135.0K | $-35.0K | $269.0K | $-234.0K | $0 | $0 | $0 | $0 | $-40.0K | $0 | $0 | $0 | $34.0K | $0 | |
| Net Income | $-230M | $-633M | $-62M | $-67M | $-93M | $-130M | $-59M | $-86M | $-135M | $-134M | $-233M | $-96M | $-138M | $-116M | $-108M | $-111M | |
| EPS (Basic) | $-0.22 | $-0.62 | $-0.06 | $-0.07 | $-0.10 | $-0.15 | $-0.07 | $-0.12 | $-0.20 | $-0.20 | $-0.37 | $-0.19 | $-0.32 | $-0.27 | $-0.26 | $-0.28 | |
| EPS (Diluted) | $-0.22 | $-0.62 | $-0.06 | $-0.07 | $-0.10 | $-0.15 | $-0.08 | $-0.14 | $-0.20 | $-0.20 | $-0.37 | $-0.19 | $-0.32 | $-0.27 | $-0.26 | $-0.28 | |
| Shares (Basic) | 1,050,070,000 | 1,026,874,000 | · | 946,601,000 | 888,216,000 | 853,162,000 | · | 695,895,000 | 686,938,000 | 672,831,000 | · | 498,375,000 | 437,456,657 | 428,381,485 | · | 400,059,707 | |
| Shares (Diluted) | 1,050,070,000 | 1,026,874,000 | · | 946,601,000 | 888,216,000 | 853,162,000 | · | 697,961,000 | 686,938,000 | 672,831,000 | · | 498,375,000 | 437,456,657 | 428,381,485 | · | 400,059,707 | |
| EBITDA | $-62M | $-65M | · | $-56M | $-71M | $-61M | · | $-80M | $-99M | $-91M | · | $-80M | $-85M | $-107M | · | $-91M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $76M | $205M | $88M | $60M | $138M | $61M | $143M | $112M | $130M | $133M | $265M | $178M | $44M | $88M | $105M | $104M | |
| Short-term Investments | $282M | $176M | $154M | $198M | $16M | $931.0K | $6M | $18M | $88M | $37M | · | $12M | $2M | $3M | · | $7M | |
| Receivables | $53M | $43M | $43M | $32M | $22M | $17M | $2M | $4M | $1M | · | · | · | · | · | · | · | |
| Inventory | $2M | $547.0K | $910.0K | $7M | $7M | $8M | $8M | $2M | $2M | · | · | · | · | · | · | · | |
| Prepaid Expense | · | $28M | $29M | $33M | $26M | $22M | $24M | $26M | $21M | $23M | · | $23M | $19M | $21M | · | $31M | |
| Other Current Assets | · | $3M | $2M | $3M | $2M | $2M | $1M | $1M | $480.0K | $3M | · | $4M | $5M | $4M | · | $3M | |
| Current Assets | $439M | $453M | $315M | $329M | $208M | $109M | $185M | $163M | $243M | $196M | · | $215M | $67M | $113M | · | $143M | |
| PP&E (Net) | $114M | $113M | $114M | $130M | $133M | $135M | $137M | $139M | $142M | $144M | · | $152M | $151M | $154M | · | $130M | |
| PP&E (Gross) | · | $229M | $227M | $239M | $239M | $238M | $237M | $235M | $234M | $232M | · | $233M | $229M | $228M | · | $195M | |
| Accum. Depreciation | · | $116M | $112M | $109M | $106M | $103M | $100M | $96M | $92M | $88M | · | $81M | $78M | $73M | · | $65M | |
| Goodwill | · | $910.0K | $910.0K | $910.0K | $910.0K | $910.0K | $910.0K | $910.0K | · | · | · | · | · | · | · | · | |
| Intangibles | · | $12M | $13M | $14M | $14M | $14M | · | $15M | $16M | $17M | · | $18M | $19M | $20M | · | $20M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $4M | $3M | $3M | · | $3M | $4M | $5M | · | $5M | |
| Total Assets | $629M | $647M | $502M | $519M | $402M | $304M | $383M | $365M | $444M | $401M | · | $432M | $291M | $343M | · | $353M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | · | · | $34M | · | $20M | |
| Accrued Liabilities | · | $48M | $47M | $44M | $36M | $28M | $41M | $44M | $35M | $33M | · | $65M | $62M | $54M | · | $46M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $482M | · | · | · | |
| Current Liabilities | $77M | $68M | $62M | $57M | $51M | $49M | $55M | $61M | $62M | $54M | · | $90M | $613M | $565M | · | $71M | |
| Capital Leases | $31M | $33M | $33M | $34M | $36M | $33M | $35M | $37M | $36M | $38M | · | $39M | $45M | $46M | · | $50M | |
| Other Non-current Liabilities | $510.0K | $472.0K | $424.0K | $702.0K | $710.0K | $370.0K | $319.0K | $705.0K | $704.0K | $1M | · | $467.0K | $473.0K | $462.0K | · | $569.0K | |
| Total Liabilities | $1.67B | $1.52B | $1.00B | $1.04B | $972M | $894M | $871M | $1.11B | $1.14B | $1.09B | · | $843M | $936M | $875M | · | $782M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $482M | · | · | · | |
| Common Stock | $105.0K | $104.0K | $101.0K | $98.0K | $91.0K | $85.0K | $85.0K | $70.0K | $69.0K | $68.0K | · | $67.0K | $44.0K | $43.0K | · | $40.0K | |
| Retained Earnings | $-4.59B | $-4.36B | $-3.73B | $-3.66B | $-3.60B | $-3.50B | $-3.38B | $-3.32B | $-3.23B | $-3.10B | · | $-2.73B | $-2.63B | $-2.49B | · | $-2.27B | |
| AOCI | $27M | $27M | $29M | $5M | $13M | $20M | $1M | $103.0K | $-8.0K | $-7.0K | · | $792.0K | $-40.0K | $-33.0K | · | $-190.0K | |
| Stockholders' Equity | $-1.05B | $-870M | $-500M | $-524M | $-571M | $-591M | $-489M | $-745M | $-698M | $-692M | · | $-412M | $-642M | $-529M | · | $-427M | |
| Liabilities + Equity | $629M | $647M | $502M | $519M | $402M | $304M | $383M | $365M | $444M | $401M | · | $432M | $291M | $343M | · | $353M | |
| Shares Outstanding | 1,053,221,645 | 1,047,341,146 | 1,011,800,008 | 984,965,179 | 915,625,053 | 853,556,193 | 852,904,340 | 696,831,296 | 691,793,169 | 677,003,411 | 670,867,344 | 667,703,040 | 440,673,897 | 421,569,115 | 421,569,115 | 400,304,106 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | |
| Stock-based Comp | $9M | $8M | $9M | $9M | $10M | $10M | $9M | $7M | $10M | $8M | $13M | $14M | $11M | $11M | $9M | $11M | |
| Amort. of Intangibles | · | · | · | · | $500.0K | $500.0K | · | $500.0K | $500.0K | $500.0K | · | $500.0K | $500.0K | $500.0K | $400.0K | $600.0K | |
| Other Non-cash | · | $545M | · | · | · | $30M | · | · | · | $14M | · | · | · | $16M | · | · | |
| Operating Cash Flow | $-66M | $-75M | $-70M | $-69M | $-80M | $-86M | $-85M | $-99M | $-100M | $-107M | $-115M | $-87M | $-80M | $-84M | $-91M | $-81M | |
| CapEx | $4M | $2M | $903.0K | $741.0K | $1M | $1M | $2M | $3M | $724.0K | $1M | $8M | $6M | $9M | $8M | $19M | $16M | |
| Investing Cash Flow | $-107M | $-32M | $44M | $-181M | $-16M | $4M | $10M | $65M | $-51M | $-36M | $2M | $-16M | $-9M | $-8M | $-19M | $-1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $47M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $47M | · | · | |
| Financing Cash Flow | $44M | $224M | $55M | $174M | $173M | $-982.0K | $107M | $16M | $149M | $10M | $201M | $238M | $43M | $77M | $110M | $124M | |
| Net Change in Cash | $-130M | $117M | $28M | $-77M | $77M | $-83M | $32M | $-18M | $-3M | $-132M | $87M | $134M | $-45M | $-16M | $480.0K | $42M | |
| Taxes Paid | · | · | $0 | $0 | $0 | $0 | $0 | $2.0K | $5.0K | $8.0K | $8.0K | $0 | $0 | $0 | $-1.0K | $3.0K | |
| Free Cash Flow | · | $-77M | · | · | · | $-87M | · | · | · | $-108M | · | · | · | $-93M | · | · | |
| Levered FCF | · | · | · | · | · | $-102M | · | · | · | $-138M | · | · | · | $-123M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -120.4% | -157.9% | · | -173.5% | -269.8% | -390.1% | · | -1314.3% | -9487.4% | -237990.0% | · | -97726.8% | -207670.7% | -30994.4% | · | -76952.5% | |
| Net Margin | -449.6% | -1431.4% | · | -209.8% | -350.3% | -784.9% | · | -1404.0% | -12852.3% | -335272.5% | · | -116563.4% | -336290.2% | -32317.5% | · | -94015.2% | |
| Pretax Margin | -449.6% | -1431.5% | · | -209.9% | -349.3% | -786.5% | · | -1404.4% | -12854.2% | -335325.0% | · | -116636.6% | -337104.9% | -32384.2% | · | -94204.2% | |
| EBITDA Margin | -120.4% | -148.0% | · | -173.5% | -269.8% | -366.9% | · | -1314.3% | -9487.4% | -226602.5% | · | -97726.8% | -207670.7% | -29694.2% | · | -76952.5% | |
| ROA | -44.7% | -133.2% | · | -15.2% | -21.9% | -36.8% | · | -21.5% | -36.6% | -36.0% | · | -24.3% | -45.3% | -31.7% | · | -39.1% | |
| ROE | 28.5% | 86.6% | · | 10.6% | 14.6% | 20.2% | · | 14.8% | 20.1% | 22.0% | · | 22.8% | 26.0% | 26.9% | · | 36.1% | |
| ROIC | 5.9% | 8.0% | · | 10.6% | 12.5% | 10.9% | · | 10.8% | 14.2% | 13.8% | · | 19.5% | 53.1% | 21.1% | · | 21.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 6.7 | · | 5.8 | 4.1 | 2.2 | · | 2.7 | 3.9 | 3.6 | · | 2.4 | 0.1 | 0.2 | · | 2.0 | |
| Quick Ratio | 5.4 | 6.2 | · | 5.1 | 3.5 | 1.6 | · | 2.2 | 3.5 | 3.2 | · | 2.1 | 0.1 | 0.2 | · | 1.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | -0.8 | · | · | · | |
| Interest Coverage | · | · | · | -3.6 | -4.6 | -4.2 | · | -2.7 | -3.3 | -3.2 | · | -2.3 | -2.6 | -3.7 | · | -5.4 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 1.5 | · | 1.8 | 2.3 | 1.9 | · | 2.9 | 1.9 | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.99 | $-0.83 | · | $-0.53 | $-0.62 | $-0.69 | · | $-1.07 | $-1.01 | $-1.02 | · | $-0.62 | $-1.46 | $-1.25 | · | $-1.07 | |
| Revenue / Share | $0.05 | $0.04 | · | $0.03 | $0.03 | $0.02 | · | $0.01 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.07 | · | · | · | $-0.10 | · | · | · | $-0.16 | · | · | · | $-0.20 | · | · | |
| Cash / Share | $0.07 | $0.20 | · | $0.06 | $0.15 | $0.07 | · | $0.16 | $0.19 | $0.20 | · | $0.27 | $0.10 | $0.21 | · | $0.26 | |
| EPS (TTM) | $-0.97 | $-0.85 | · | $-0.40 | $-0.47 | $-0.57 | · | $-0.91 | $-0.96 | $-1.08 | · | $-1.04 | $-1.13 | $-1.05 | · | $-1.01 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $166M | $141M | · | $83M | $57M | $31M | · | $7M | $1M | $302.0K | · | $556.0K | $592.0K | $586.0K | · | $557.0K | |
| Net Income TTM | $-992M | $-855M | · | $-349M | $-367M | $-409M | · | $-588M | $-598M | $-601M | · | $-458M | $-473M | $-430M | · | $-400M | |
| Market Cap | $9.22B | $8.03B | · | $2.42B | $2.42B | $2.57B | · | $2.59B | $4.37B | $3.64B | · | $1.13B | $1.23B | $767M | · | $1.99B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $939M | $1.66B | · | · | · | |
| P/E | -9.0 | -9.0 | · | -6.2 | -5.6 | -5.3 | · | -4.1 | -6.6 | -5.0 | · | -1.6 | -2.5 | -1.7 | · | -4.9 | |
| P/S | 55.6 | 57.0 | · | 29.4 | 42.7 | 82.3 | · | 353.5 | 3342.6 | 12038.1 | · | 2029.5 | 2069.4 | 1309.3 | · | 3571.8 | |
| P/B | -8.8 | -9.2 | · | -4.6 | -4.2 | -4.3 | · | -3.5 | -6.3 | -5.3 | · | -2.7 | -1.9 | -1.5 | · | -4.7 | |
| P / Cash Flow | · | -106.6 | · | · | · | -29.9 | · | · | · | -34.0 | · | · | · | -9.1 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 1688.2 | 2805.8 | · | · | · | |
| Earnings Yield | -11.1% | -11.1% | · | -16.3% | -17.8% | -18.9% | · | -24.5% | -15.2% | -20.1% | · | -61.5% | -40.6% | -57.7% | · | -20.3% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $113M | $15M | $622.0K | $240.0K | $934.0K |
| Faaliyet Kâr Marjı % | -226.0% | -2334.2% | -58239.5% | -146374.2% | -35361.9% |
| Net Gelir | $-351M | $-414M | $-583M | $-417M | $-347M |
| Seyreltilmiş Hisse Başı Kâr | $-0.38 | $-0.62 | $-1.15 | $-1.04 | $-0.89 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | 0.0 | · | · |
| Cari Oran | 5.1 | 3.4 | 5.0 | 0.3 | 0.9 |
| Cari Oran | 4.6 | 2.8 | 4.6 | 0.2 | 0.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-309M | $-398M | $-397M | $-416M | $-308M |
Kurumsal Sahipler (13F) 447 dosya · $2.0B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
447
Tutulan Değer
$2.0B
Yeni pozisyonlar
70
Çıkan pozisyonlar
45
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 70 (-104 önceki Ç'ye göre) | 45 (+16 önceki Ç'ye göre) | 147 (+6 önceki Ç'ye göre) | 110 (+52 önceki Ç'ye göre) | +21.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $298.398.958 | 34.083.262 | 14,71% | Hisse senetleri |
| STATE STREET CORP | $187.343.325 | 21.398.438 | 9,24% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $156.398.541 | 17.863.911 | 7,71% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $137.379.774 | 15.691.579 | 6,77% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $101.129.171 | 11.551.019 | 4,99% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $97.155.163 | 11.097.106 | 4,79% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $86.230.624 | 9.847.896 | 4,25% | Hisse senetleri |
| VANGUARD GROUP INC | $64.898.969 | 32.777.257 | 3,20% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $58.057.776 | 6.627.600 | 2,86% | Alım opsiyonu |
| MILLENNIUM MANAGEMENT LLC | $48.851.088 | 5.579.793 | 2,41% | Hisse senetleri |
| LMR Partners LLP | $34.879.045 | 3.983.900 | 1,72% | Alım opsiyonu |
| CITADEL ADVISORS LLC | $33.592.060 | 3.836.900 | 1,66% | Alım opsiyonu |
| NORTHERN TRUST CORP | $31.213.746 | 3.565.248 | 1,54% | Hisse senetleri |
| MORGAN STANLEY | $30.053.096 | 3.432.678 | 1,48% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $28.316.099 | 3.234.277 | 1,40% | Hisse senetleri |
| UBS Group AG | $27.978.598 | 3.195.728 | 1,38% | Hisse senetleri |
| GREAT POINT PARTNERS LLC | $26.272.004 | 3.000.800 | 1,30% | Satım opsiyonu |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25.289.754 | 2.888.607 | 1,25% | Hisse senetleri |
| Woodline Partners LP | $21.889.155 | 2.500.189 | 1,08% | Hisse senetleri |
| SEB Asset Management AB | $21.424.757 | 2.447.150 | 1,06% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $21.120.019 | 2.412.338 | 1,04% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $19.125.201 | 2.184.489 | 0,94% | Hisse senetleri |
| JANE STREET GROUP, LLC | $17.547.647 | 2.004.300 | 0,87% | Alım opsiyonu |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $15.075.252 | 1.721.902 | 0,74% | Hisse senetleri |
| FEDERATED HERMES, INC. | $14.999.066 | 1.713.200 | 0,74% | Hisse senetleri |
| CITADEL ADVISORS LLC | $14.898.384 | 1.701.700 | 0,73% | Satım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14.700.156 | 1.678.100 | 0,72% | Satım opsiyonu |
| ROYAL BANK OF CANADA | $13.506.000 | 1.542.717 | 0,67% | Hisse senetleri |
| JPMORGAN CHASE & CO | $12.871.781 | 1.450.180 | 0,63% | Hisse senetleri |
| Bank of New York Mellon Corp | $11.510.727 | 1.314.760 | 0,57% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $10.634.409 | 1.214.667 | 0,52% | Hisse senetleri |
| Cetera Investment Advisers | $9.984.867 | 1.140.476 | 0,49% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $9.012.388 | 1.029.399 | 0,44% | Hisse senetleri |
| LPL Financial LLC | $8.939.354 | 1.021.057 | 0,44% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $7.670.411 | 875.621 | 0,38% | Hisse senetleri |
| Nuveen, LLC | $7.525.903 | 859.612 | 0,37% | Hisse senetleri |
| Pictet Asset Management Holding SA | $7.433.121 | 847.659 | 0,37% | Hisse senetleri |
| Squarepoint Ops LLC | $6.662.494 | 760.993 | 0,33% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $6.452.703 | 737.031 | 0,32% | Hisse senetleri |
| BARCLAYS PLC | $6.394.093 | 730.336 | 0,32% | Hisse senetleri |
| Swiss National Bank | $6.321.110 | 722.000 | 0,31% | Hisse senetleri |
| Clearwater Capital Advisors, LLC | $6.281.923 | 717.524 | 0,31% | Hisse senetleri |
| Trexquant Investment LP | $6.098.269 | 696.547 | 0,30% | Hisse senetleri |
| ALLEN HOLDING INC /NY | $6.019.684 | 687.571 | 0,30% | Hisse senetleri |
| Kercheville Advisors, LLC | $5.644.219 | 644.685 | 0,28% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $5.097.004 | 582.182 | 0,25% | Hisse senetleri |
| CITIGROUP INC | $4.817.667 | 550.276 | 0,24% | Hisse senetleri |
| Voleon Capital Management LP | $4.807.598 | 549.126 | 0,24% | Hisse senetleri |
| D.A. DAVIDSON & CO. | $4.718.279 | 538.924 | 0,23% | Hisse senetleri |
| SHEETS SMITH WEALTH MANAGEMENT | $4.487.568 | 512.572 | 0,22% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Cambridge Equities, LP, MP 13 Ventures, LLC, NantWorks, LLC, Nant Capital, LLC, California Capital Equity, LLC, Patrick Soon-Shiong ×5 başvurular | 06 Ağustos 2026 | 64,80% | Değişiklik | · | SEC |
| Cambridge Equities, LP (2), MP 13 Ventures, LLC (2), NantWorks, LLC (2), NantMobile, LLC (2), Nant Capital, LLC (2), California Capital Equity, LLC (2), Patrick Soon-Shiong (2) ×9 başvurular | 04 Ocak 2024 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 20 içeriden öğrenenler · 6 yöneticiler · 13 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Richard Adcock | CEO & President | 22 Şubat 2026 M | 560.344 | 0 | 0 | $0 |
| David C. Sachs | Chief Financial Officer | 22 Şubat 2026 M | 300.143 | 0 | 0 | $0 |
| Sonja Nelson | Chief Financial Officer | 12 Ocak 2021 M | 15.410 | 0 | 0 | $0 |
| Richard J. Tajak | Chief Financial Officer | 23 Mart 2017 M | 12.876 | 0 | 0 | $0 |
| Angela Wilson | Chief Financial Officer | 10 Aralık 2015 P | 3.265 | 0 | 0 | $0 |
| Regan J Lauer | Chief Accounting Officer | 22 Şubat 2026 M | 115.875 | 0 | 0 | $0 |
| Cheryl Cohen | Yönetim kurulu üyesi | 02 Temmuz 2026 M | 125.386 | 0 | 1 | $-1.246.495 |
| Christobel Selecky | Yönetim kurulu üyesi | 01 Temmuz 2026 M | 0 | 0 | 6 | $-2.997.697 |
| Barry J. Simon | Yönetim kurulu üyesi | 24 Haziran 2026 S | 2.802.788 | 0 | 7 | $-4.141.241 |
| Linda Maxwell | Yönetim kurulu üyesi | 09 Haziran 2026 A | · | 0 | 0 | $0 |
| Michael D Blaszyk | Yönetim kurulu üyesi | 09 Haziran 2026 A | 71.915 | 0 | 0 | $0 |
| Bruce Wendel | Yönetim kurulu üyesi | 09 Haziran 2026 A | · | 0 | 0 | $0 |
| Wesley Clark | Yönetim kurulu üyesi | 09 Haziran 2026 A | 8.000 | 0 | 0 | $0 |
| John C Thomas | Yönetim kurulu üyesi | 10 Aralık 2020 S | 207.477 | 0 | 0 | $0 |
| Frederick W Driscoll | Yönetim kurulu üyesi | 11 Ağustos 2020 S | 109.235 | 0 | 0 | $0 |
| Steve Gorlin | Yönetim kurulu üyesi | 10 Haziran 2020 A | 92.592 | 0 | 0 | $0 |
| Richard Kusserow | Yönetim kurulu üyesi | 09 Haziran 2017 A | 394.053 | 0 | 0 | $0 |
| John T Potts JR | Yönetim kurulu üyesi | 09 Haziran 2017 A | 159.253 | 0 | 0 | $0 |
| Patrick Soon-Shiong | · | 10 Şubat 2025 A | · | 0 | 0 | $0 |
| John Owen Brennan | · | 11 Haziran 2024 A | 25.000 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 35 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IDNA · iShares Trust | 2,82% | 934.908 SH | 11 Eylül 2026 | Günlük |
| BBP · ETFis Series Trust I | 1,39% | 191.148 NS | 31 Temmuz 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,66% | 74.882 SH | 02 Ekim 2026 | Günlük |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,65% | 524.194 NS | 31 Temmuz 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,61% | 423.471 NS | 31 Temmuz 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,53% | 231.217 SH | 02 Ekim 2026 | Günlük |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,25% | 470.597 NS | 31 Temmuz 2026 | N-PORT |
| IBB · iShares Trust | 0,21% | 2.871.255 SH | 11 Eylül 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,20% | 414.467 SH | 19 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,20% | 3.629.373 SH | 11 Eylül 2026 | Günlük |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,20% | 157.387 NS | 31 Temmuz 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,17% | 5.786 NS | 31 Temmuz 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,17% | 390.556 SH | 19 Ağustos 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 102.487 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 2.224.716 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,10% | 9.868.418 SH | 11 Eylül 2026 | Günlük |
| ISCG · iShares Trust | 0,10% | 119.028 SH | 11 Eylül 2026 | Günlük |
| VBK · VANGUARD INDEX FUNDS | 0,09% | 4.852.894 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,09% | 185.076 NS | 31 Temmuz 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,07% | 62.633 NS | 31 Temmuz 2026 | N-PORT |
| TECB · iShares Trust | 0,06% | 36.976 SH | 11 Eylül 2026 | Günlük |
| ESML · iShares Trust | 0,05% | 182.507 SH | 11 Eylül 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,05% | 1.082.841 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,04% | 8.407.771 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 170.988 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 3.724.582 SH | 19 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,03% | 24.490 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 56.428 SH | 02 Ekim 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 105.730 SH | 11 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 437.718 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,00% | 948 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 11.599.962 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 31.790 SH | 19 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 17.015 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 57.890 SH | 11 Eylül 2026 | Günlük |
IBRX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 10 analist
AL
Medyan hedef
$12.00
+16,7%
4 40,0%
Güçlü Al
5 50,0%
Al
1 10,0%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
4 analist · 2026-09-27Ortalama hedef $12.75 +24,0%
← Tüm hedeflerin altında
Mevcut fiyat $10.29
Düşük$12.00
Ortalama$12.75
Yüksek$15.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | · |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | · |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | · |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | · |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | · |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | · |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | · |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | · |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | · |
Son Haberler Bu şirketten bahseden son manşetler
ImmunityBio (IBRX): One of the Best Performing Growth Stocks So Far in 2026
Yahoo Finance · 3 ay, 3 hafta önce
ImmunityBio Inc. (IBRX): One of the Most Shorted Mid-Cap Stocks to Buy Now
Yahoo Finance · 3 ay, 3 hafta önce
Neden ImmunityBio Hissesi Bugün Çok Daha Yüksek Seviyelerde?
Yahoo Finance · 4 ay, 1 hafta önce
Neden ImmunityBio Hisseleri Pazartesi Günü Düştü
Nasdaq · 5 ay, 3 hafta önce
ImmunityBio Inc. (IBRX) Duyurur ANKTIVA® Onayını Macau SAR, Çin'de
Yahoo Finance · 6 ay, 1 hafta önce
ImmunityBio (IBRX) NCCN Klinik Uygulama Kılavuzlarını Papiller Sadece NMIBC İçin ANKTIVA'yı Kapsayacak Şekilde Güncellediğini Duyurdu
Yahoo Finance · 6 ay, 1 hafta önce
Bugünkü Borsa, 24 Mart: Petrol, Yapay Zeka ve Özel Kredi Korkuları Piyasaları Baskılıyor
Nasdaq · 6 ay, 1 hafta önce
ImmunityBio Hissesi Neden Bugün Yüzde 20'den Fazla Düşüş Yaşadı?
Yahoo Finance · 6 ay, 1 hafta önce
Jim Cramer'den ImmunityBio Hakkında: “Bu Hisse Büyülü Düşünce Döneminin Bir Parçası”
Yahoo Finance · 6 ay, 1 hafta önce
ImmunityBio (IBRX) Kârda %17 Kaybediyor - Gün İçi Yüksekten Sonra
finance.yahoo.com · 7 ay önce
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 4, 2026